NASDAQ:CBUS Cibus (CBUS) Stock Price, News & Analysis $2.09 -0.11 (-5.00%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$2.10 +0.01 (+0.24%) As of 03/25/2025 05:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Cibus Stock (NASDAQ:CBUS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cibus alerts:Sign Up Key Stats Today's Range$2.02▼$2.2050-Day Range$1.88▼$2.7252-Week Range$1.80▼$23.18Volume160,197 shsAverage Volume167,107 shsMarket Capitalization$55.29 millionP/E RatioN/ADividend YieldN/APrice Target$22.17Consensus RatingBuy Company OverviewCibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.Read More… Remove Ads Cibus Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks39th Percentile Overall ScoreCBUS MarketRank™: Cibus scored higher than 39% of companies evaluated by MarketBeat, and ranked 105th out of 148 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingBuy Consensus RatingCibus has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageCibus has only been the subject of 2 research reports in the past 90 days.Read more about Cibus' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Cibus are expected to decrease in the coming year, from ($2.96) to ($3.02) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cibus is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cibus is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCibus has a P/B Ratio of 0.17. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Cibus' valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.86% of the float of Cibus has been sold short.Short Interest Ratio / Days to CoverCibus has a short interest ratio ("days to cover") of 12.7, which indicates bearish sentiment.Change versus previous monthShort interest in Cibus has recently increased by 1.40%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCibus does not currently pay a dividend.Dividend GrowthCibus does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted9.86% of the float of Cibus has been sold short.Short Interest Ratio / Days to CoverCibus has a short interest ratio ("days to cover") of 12.7, which indicates bearish sentiment.Change versus previous monthShort interest in Cibus has recently increased by 1.40%, indicating that investor sentiment is decreasing. News and Social Media1.8 / 5News Sentiment0.32 News SentimentCibus has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.83 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 18 news articles for Cibus this week, compared to 3 articles on an average week. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Cibus insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $49,738.00 in company stock.Percentage Held by Insiders49.40% of the stock of Cibus is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 33.81% of the stock of Cibus is held by institutions.Read more about Cibus' insider trading history. Receive CBUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cibus and its competitors with MarketBeat's FREE daily newsletter. Email Address CBUS Stock News HeadlinesCibus negotiations with EU moving forward is significant, says CanaccordMarch 25 at 9:21 PM | markets.businessinsider.comHC Wainwright Predicts Cibus' Q1 Earnings (NASDAQ:CBUS)March 24 at 1:13 AM | americanbankingnews.comNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.March 26, 2025 | Brownstone Research (Ad)Cibus, Inc. (NASDAQ:CBUS) Q4 2024 Earnings Call TranscriptMarch 22, 2025 | msn.comCibus, Inc. Earnings Call: Strategic Progress Amid ChallengesMarch 21, 2025 | tipranks.comCibus, Inc.: Cibus Reports Fourth Quarter Financial Results and Provides Business UpdateMarch 21, 2025 | finanznachrichten.deCibus outlines advanced gene editing initiatives with potential revenue milestones by 2026March 21, 2025 | msn.comCibus reports Q4 EPS (87c), consensus (76c)March 21, 2025 | markets.businessinsider.comSee More Headlines CBUS Stock Analysis - Frequently Asked Questions How have CBUS shares performed this year? Cibus' stock was trading at $2.78 at the beginning of 2025. Since then, CBUS stock has decreased by 24.8% and is now trading at $2.09. View the best growth stocks for 2025 here. How were Cibus' earnings last quarter? Cibus, Inc. (NASDAQ:CBUS) issued its earnings results on Thursday, March, 20th. The company reported ($0.87) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.68) by $0.19. The business had revenue of $1.21 million for the quarter, compared to analysts' expectations of $1.13 million. Cibus had a negative net margin of 10,724.78% and a negative trailing twelve-month return on equity of 28.17%. When did Cibus IPO? Cibus (CBUS) raised $100 million in an initial public offering on Thursday, February 14th 2019. The company issued 6,700,000 shares at $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Piper Jaffray acted as the underwriters for the IPO. Who are Cibus' major shareholders? Cibus' top institutional investors include Geode Capital Management LLC (1.48%), Granby Capital Management LLC (0.76%), Northern Trust Corp (0.57%) and Millennium Management LLC (0.48%). Insiders that own company stock include Gregory Francis William Gocal, Carlo Broos and Gerhard Prante. View institutional ownership trends. How do I buy shares of Cibus? Shares of CBUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cibus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cibus investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Advanced Micro Devices (AMD), Visa (V), Netflix (nflx) and JPMorgan Chase & Co. (JPM). Company Calendar Last Earnings3/20/2025Today3/25/2025Next Earnings (Estimated)5/08/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Agricultural chemicals Sub-IndustryChemicals Current SymbolNASDAQ:CBUS CIK1705843 Webwww.calyxt.com Phone(858) 450-0008FaxN/AEmployees48Year FoundedN/APrice Target and Rating Average Stock Price Target$22.17 High Stock Price Target$25.00 Low Stock Price Target$18.00 Potential Upside/Downside+960.6%Consensus RatingBuy Rating Score (0-4)3.25 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($10.76) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-267,640,000.00 Net Margins-10,724.78% Pretax Margin-12,860.54% Return on Equity-28.17% Return on Assets-13.39% Debt Debt-to-Equity RatioN/A Current Ratio1.44 Quick Ratio1.44 Sales & Book Value Annual Sales$4.26 million Price / Sales12.97 Cash Flow$7.46 per share Price / Cash Flow0.28 Book Value$12.38 per share Price / Book0.17Miscellaneous Outstanding Shares26,456,000Free Float13,387,000Market Cap$55.29 million OptionableOptionable Beta2.04 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (NASDAQ:CBUS) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cibus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cibus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.